Posted on

ABBOTT LAUNCHES THIRD COVID-19 TEST, A LABORATORY-BASED ANTIBODY BLOOD TEST

Architect i2000 960x430 1

the staff of the Ridgewood blog

ABBOTT PARK Ill., Abbott (NYSE: ABT) announced today the launch of its third COVID-19 test, a lab-based serology blood test for the detection of the antibody, IgG, that identifies if a person has had the novel coronavirus (COVID-19). Antibody testing is an important next step to tell if someone has been previously infected. It will provide more understanding of the virus, including how long antibodies stay in the body and if they provide immunity. This type of knowledge could help support the development of treatments and vaccines.

Continue reading ABBOTT LAUNCHES THIRD COVID-19 TEST, A LABORATORY-BASED ANTIBODY BLOOD TEST

Posted on

Governor Murphy Announces Acquisition of 15 Abbott ID NOW to Expand Access to COVID-19 Testing in New Jersey

IDNOW LEFT 960x430 1

the staff of the Ridgewood blog

 

Ridgewood NJ,  Governor Phil Murphy today announced the acquisition of 15 point-of-care ID NOW testing instruments from the federal government to expand access to COVID-19 testing in New Jersey. The portable, rapid testing machines will be dispersed to health care systems throughout the state, will be able to test for COVID-19 and process specimens in approximately 5-13 minutes.

Continue reading Governor Murphy Announces Acquisition of 15 Abbott ID NOW to Expand Access to COVID-19 Testing in New Jersey